+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Assisted Reproductive Technology Market Research and Forecast 2022-2028

  • Report
  • 125 Pages
  • July 2022
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 4621250
UP TO OFF until Dec 31st 2022

Assisted Reproductive Technology Market by Technology (In Vitro Fertilization and Others), By Procedure (Frozen Donor, Frozen Non-Donor, Fresh Donor, Fresh Non-Donor, Embryo Banking) - Global Industry Share, Growth, Competitive Analysis and Forecast Period 2022-2028

The global assisted reproductive technology market is growing at a CAGR of 8.7% during the forecast period. ART is a procedure to achieve pregnancy by techniques such as in vitro fertilization, Surrogacy, and fertility medication. The global ART market is emerging at a rapid pace due to the impact of various factors such as the development of healthcare infrastructure and preimplantation genetic diagnosis. Government initiatives for R&D as well as the growing reproductive problems also drive the growth of the market. The increasing trends of assisted reproductive technology coupled with the increasing infertility rate are the major growth factors for the in-vitro fertilization and hence assisted reproductive technology market.

Segmental Outlook

The global market assisted reproductive technology market is segmented on the basis of technology, and procedures. By technology, the market is segmented into In Vitro Fertilization and others such as Zygote Intrafallopian Transfer (ZIFT) and Gamete Intrafallopian Transfer (GIFT). Further, based on the procedure, the market is divided into the donor, frozen non-donor, fresh donor, fresh non-donor, and embryo banking.

The IVF is projected to grow at a considerable rate during the forecast period. The segmental growth is attributed to the high procedural success rate coupled with continuous advancement. Further, the increasing number of IVF treatments has encouraged more insurance providers to cover these procedures. This has resulted in competitive pricing and has moderated the treatment costs.

Regional Outlooks

Geographically, the study of the global assisted reproductive technology market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. Europe is estimated to hold a prominent share in the market.

Global Assisted Reproductive Technology Market by Region, 2020 (%)

Global Assisted Reproductive Technology Market by Region

North America is projected to exhibit significant growth during the forecast period. This is due to the high awareness about various fertility options, favorable government support for IVF, and various technological and procedure up-gradation. Asia-Pacific is also projected to exhibit considerable growth. China contributed a significant share to the Asia-Pacific assisted reproductive technology market while India is projected to exhibit the highest growth rate during the forecast period.

Market Players Outlook

Moreover, the study of the report covers the analysis of various players operating in the market. Some of the key players covered in the report include Anecova Sa, Celmatix Inc., Cooper Surgical Inc., Irvine Scientific Sales Co., Inc., and others. In order to survive in the market, these players adopt different marketing strategies such as mergers and acquisitions, product launches, and geographical expansion. With technological advancement, these companies are coming with innovations and techniques with improved products and services in order to provide the best possible treatment. In 2021, TMRW launched the world’s first automated cryo specimen management solution for embryos and eggs used in IVF treatment. It has been installed in infertility clinics in the US.

The Report Covers

  • Market value data analysis of 2020 and forecast to 2027.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global Assisted Reproductive Technology Market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market

Table of Contents

1. Report Summary
  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Assisted Reproductive Technology Market
  • Recovery Scenario of Global Assisted Reproductive Technology Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. By Technology
5.1.1. In Vitro Fertilization
5.1.2. Others (Gamete Intrafallopian Transfer)
5.2. By Procedure
5.2.1. Frozen Donor
5.2.2. Frozen Non-Donor
5.2.3. Fresh Donor
5.2.4. Fresh Non-Donor
5.2.5. Embryo Banking
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Anecova Sa
7.2. Celmatix Inc.
7.3. Cooper Surgical Inc.
7.4. Emd Serono, Inc.
7.5. Esco Micro Pte Ltd.
7.6. European Sperm Bank
7.7. Ferring Pharmaceuticals
7.8. Hamilton Throne Ltd.
7.9. IKSInternational B.V.
7.10. Incept Biosystems, Inc.
7.11. Invo Bioscience Inc
7.12. Irvine Scientific Sales Co., Inc.
7.13. IvftechApS
7.14. Merck & Co.
7.15. Nidacon International AB
7.16. Nikon Instruments, Inc.
7.17. PantecBiosolutionsAG
7.18. Planer Plc Group
7.19. Smiths Medical, Inc.
7.20. Vitrolife

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Anecova Sa
  • Celmatix Inc.
  • Cooper Surgical Inc.
  • Emd Serono, Inc.
  • Esco Micro Pte Ltd.
  • European Sperm Bank
  • Ferring Pharmaceuticals
  • Hamilton Throne Ltd.
  • IKSInternational B.V.
  • Incept Biosystems, Inc.
  • Invo Bioscience Inc
  • Irvine Scientific Sales Co., Inc.
  • IvftechApS
  • Merck & Co.
  • Nidacon International AB
  • Nikon Instruments, Inc.
  • PantecBiosolutionsAG
  • Planer Plc Group
  • Smiths Medical, Inc.
  • Vitrolife